Business News — September 30, 2026 — Evening Update — Last 24 Hours (Pacific Time)

Executive Summary

September 30 was a packed day for corporate news, headlined by Micron's record $54 billion fiscal year revenue driven by AI-fueled memory demand, and a wave of major deals spanning energy infrastructure, defense, pharma, and media. Leadership reshuffles were widespread — from General Mills and Mattel naming new CEOs to Levi Strauss and Hartford Financial appointing new CFO and CEO successors — while the AI infrastructure buildout continued to dominate capital allocation decisions across sectors.

Major Deals & Corporate Actions

🟢 Related Companies / NextEra Energy (NEE) — $22B Texas Power Plant for Data Centers

• Details: Related Companies and NextEra Energy Resources, partnering with Lewis Energy Group, plan to develop a $22 billion power plant in Encinal, Texas, specifically to serve data center demand.
• Significance: One of the largest single energy infrastructure commitments tied directly to AI data center growth.

🟢 Constellation Energy (CEG) / Amazon (AMZN) — Long-Term Nuclear Power Deal

• Details: Long-term power purchase agreement signed for nuclear plant expansion; financial terms not disclosed.
• Significance: Signals continued Big Tech appetite for carbon-free baseload power to fuel AI workloads.

🟢 Synopsys (SNPS) / Amazon — $1B+ Multi-Year Chip Design Agreement

• Details: Multi-year agreement valued at over $1 billion for chip design collaboration.
• Significance: Reinforces Synopsys's position at the center of the AI chip design ecosystem, alongside its separately announced OpenAI partnership.

🟢 Hormel Foods (HRL) — Acquires Brakebush for $1.055 Billion

• Details: Definitive agreement to acquire Brakebush; no expected close date stated.
• Significance: A significant bolt-on for Hormel's protein portfolio in a challenging consumer environment.

🟢 Peoples Bancorp (PEBO) — Acquires Capital Bancorp (CBNK) for $728 Million

• Details: Definitive merger agreement announced; no close date stated.
• Significance: Continues the regional banking consolidation wave.

🟢 TTM Technologies (TTMI) — Completes $1.1B Epiq Acquisition

• Details: Acquisition of EPIQ Design Solutions completed.
• Significance: Expands TTM's advanced electronics manufacturing capabilities.

🟢 HPE (HPE) — $1.2B Order from Vultr for AI Systems

• Details: Order for AMD Helios AI Rack systems; HPE also raised its FY2027 Networking revenue growth outlook.
• Significance: A landmark AI infrastructure order validating HPE's enterprise AI strategy.

🟢 MDU Resources (MDU) — Approves $3B Bakken East Pipeline

• Details: Board approved final investment decision for the Bakken East Pipeline project.
• Significance: Major midstream infrastructure commitment in the Bakken formation.

🟢 Integer Holdings (ITGR) — Antitrust Clearance for $5.7B KKR Acquisition

• Details: Early termination of HSR waiting period received; deal with KKR moves closer to close.
• Significance: Clears a key regulatory hurdle for one of the larger medtech private equity deals of the year.

🟢 Rocket Lab (RKLB) — 20-Mission Contract with Synspective

• Details: Multi-year agreement with Tokyo-based Synspective for 20 launches.
• Significance: One of Rocket Lab's largest multi-mission commitments, anchoring its launch manifest.

🟢 Amentum (AMTM) — $2.78B UK Nuclear Contract

• Details: Amentum joint venture selected as preferred supplier for an asset care contract at Sellafield Ltd.
• Significance: A major win in the growing nuclear decommissioning and maintenance market.

🟢 Choice Hotels (CHH) — Acquires Harvest Hosts for $130M

• Details: Agreement to acquire RV travel network Harvest Hosts.
• Significance: Diversifies Choice Hotels beyond traditional lodging into the fast-growing outdoor/RV travel segment.

🟢 Jardine Matheson / DFI Retail — Acquires Starbucks Asia Business for $340M

• Details: DFI Retail Group to acquire Maxim's Starbucks business through a reorganization of Maxim's Caterers interests.
• Significance: Consolidates a major Asia-Pacific food & beverage franchise under a single operator.

🔴 Madison Square Garden Sports (MSGS) — Spins Off Rangers from Knicks

• Details: Board approved separation of the New York Rangers from the New York Knicks; financial terms not stated.
• Significance: A landmark sports franchise split that could unlock significant value for shareholders of each franchise.

🔴 Enerflex (EFX/EFXT) / INNIO (INIO) — Asia Pacific Operations Divested

• Details: Enerflex completed the sale of most Asia Pacific aftermarket operations to INNIO.
• Significance: Enerflex sharpens its geographic focus while INNIO expands its aftermarket services footprint.

🔴 Brink's (BCO) — Proposes UK Unit Divestiture in Atleos Deal Review

• Details: Brink's will propose divesting its NoteMachine/TestLink UK business as part of regulatory review of its Atleos deal.
• Significance: Regulatory-driven asset sale to advance a larger strategic transaction.

🟡 Leslie's — Files Chapter 11 Bankruptcy, Plans to Cut 90% of Debt

• Details: Pool and spa care retailer filed voluntary Chapter 11 petitions; plans to eliminate approximately 90% of its debt.
• Significance: A high-profile retail bankruptcy reflecting persistent consumer spending pressure on discretionary home goods.

🟡 Vivakor (VIVK) — 1-for-15 Reverse Stock Split, Effective Oct. 5

• Details: Reverse split effective at market open October 5.
• Significance: Compliance-driven action typical of companies managing Nasdaq listing requirements.

🟡 Scienture Holdings (SCNX) — 1-for-25 Reverse Stock Split

• Details: Reverse split announced; effective date not stated.
• Significance: Another compliance-driven consolidation.

🟢 Osisko Gold (OGG) — Completes $600M Senior Notes Offering at 9.250%

• Details: $600 million in senior secured notes due 2031.
• Significance: Significant capital raise for a gold royalty/mining company, reflecting appetite for yield in the metals sector.

🟢 Trinity Capital (TRIN) — $350M Notes Offering at 7.50%

• Details: Underwritten public offering of $350 million in aggregate principal amount of notes.
• Significance: BDC tapping debt markets at a notable yield level.

🟢 Immix Biopharma (IMMX) — Closes $117.1M Stock Offering

• Details: Completion of underwritten registered offering.
• Significance: Substantial capital raise for a clinical-stage biotech.

Leadership & Governance

General Mills — Dana McNabb, currently COO, named as next CEO, succeeding Jeff Harmening. A planned internal succession at one of America's largest food companies.

Mattel (MAT) — Roger Lynch named Chairman effective October 2, 2026, and CEO (effective date not specified). Mattel's stock simultaneously hit a 52-week low, adding urgency to the leadership transition.

Hartford Financial (HIG) — Mo Tooker appointed as next CEO, effective March 2027. Current leadership remains in place through the transition period.

Levi Strauss (LEVI) — John Vandemore named EVP and CFO, effective November 1.

Paramount Skydance (PSKY) — Ynon Kreiz named Co-CEO of the combined company ahead of its merger with Warner Bros. Discovery.

Moderna (MRNA) — Juan Andres appointed Chief Operating Officer, effective October 5.

Albertsons (ACI) — Cody Perdue named Interim CFO; separately, three new directors (Bill Boltz, Chris Drumgoole, Meg Ham) added to an expanded board.

CAVA Group — John Ludeke appointed Chief Marketing Officer, effective October 12.

Hyatt Hotels (H) — Amar Lalvani named as the company's first-ever Chief Creative Officer.

Cars.com (CARS) — Trent Ziegler named CFO-Designate.

Levi Strauss (LEVI) — CFO appointment noted above.

GlobalData (DATA.L) — CFO Graham Lilley stepped down; Rob Kingston appointed as replacement.

Pliant Therapeutics (PLRX) — David Raben, M.D., named Chief Medical Officer.

Pattern to note: A striking number of companies — spanning food, insurance, retail, hospitality, and biotech — are making C-suite changes simultaneously, suggesting a broader wave of post-cycle leadership refreshes heading into 2027 planning seasons.

Stock Milestones & Price Action

📈 Highs / Positive

📉 Lows / Negative

Sector & Industry Patterns

AI Infrastructure is the dominant capital allocation theme. The day's biggest stories — the $22B NextEra/Related Texas power plant, Constellation's nuclear deal with Amazon, Synopsys's $1B+ Amazon chip design agreement, CoreWeave launching Nvidia Vera Rubin NVL72 cloud services, HPE's $1.2B Vultr AI order, and AIB Data Centers' 50 MW Nebius deal — all point to the same conclusion: the AI buildout is accelerating demand for power, chips, and compute at a scale that is reshaping capital markets. Data center infrastructure is no longer a tech story; it's an energy, real estate, and industrial story simultaneously.

Pharma and biotech had an exceptionally active day. Eli Lilly alone announced three separate clinical readouts (Foundayo cardiovascular safety, EloraTZP weight loss Phase 2b, and Ebglyss dermatitis efficacy). AbbVie reported positive Phase 2 data for both zumilokibart (atopic dermatitis) and ABBV-295 (obesity). The FDA approved Bristol Myers Squibb's CAMZYOS for pediatric cardiomyopathy. Celcuity launched Revtorpyk commercially for breast cancer. The volume of clinical catalysts in a single day is unusually high, reflecting a biotech sector in active late-stage development across multiple therapeutic areas.

Financial stress is visible in the 52-week low list. REITs (Vici, Blackstone Mortgage Trust, National Health Investors), BDCs (Blue Owl, Prospect Capital, Morgan Stanley Direct Lending), and mREITs (Annaly) are all hitting new lows simultaneously — a pattern consistent with a higher-for-longer interest rate environment compressing net interest margins and asset valuations. Meanwhile, consumer discretionary names (McDonald's, Mattel, Deckers, Churchill Downs) are also under pressure, suggesting the consumer spending slowdown is broadening.

Market Implications

The AI infrastructure investment cycle is clearly still in early innings, but the capital requirements are becoming staggering. A single power plant deal at $22 billion, a $1B+ chip design contract, and a $1.2B AI hardware order — all announced on the same day — suggest that hyperscalers and their suppliers are committing to multi-year spending programs that will underpin earnings for energy, semiconductor, and data center companies well into the decade. Investors in these supply chains have structural tailwinds that are difficult to ignore.

The simultaneous wave of 52-week lows in rate-sensitive sectors — REITs, BDCs, utilities, and mortgage REITs — is a clear signal that credit markets remain stressed and that the "higher for longer" rate narrative continues to weigh on income-oriented assets. The Leslie's bankruptcy is a canary: over-leveraged consumer-facing businesses with discretionary exposure are increasingly vulnerable. Investors should scrutinize balance sheets carefully in these sectors.

The leadership transition wave — new CEOs at General Mills, Mattel, and Hartford Financial; new CFOs at Levi Strauss, Albertsons, and Cars.com — often precedes strategic pivots, cost restructuring, or M&A activity. When multiple large companies change leadership simultaneously, it frequently signals that boards are positioning for a new operating environment. Watch for strategic plan updates and guidance revisions from these companies in the coming quarters.

Key Takeaways

• Micron (MU) — Posted record $54B fiscal year revenue with AI demand driving supply tightness; a bellwether for the memory market's AI-driven upcycle.
• NextEra Energy (NEE) / Related Companies — $22B Texas data center power plant is one of the largest single energy infrastructure commitments in recent memory, underscoring AI's power hunger.
• Constellation Energy (CEG) / Amazon (AMZN) — Long-term nuclear power deal signals Big Tech's pivot to always-on, carbon-free energy sources for AI.
• Synopsys (SNPS) — $1B+ Amazon chip design deal plus an OpenAI partnership announced the same day; SNPS is becoming the connective tissue of the AI chip design world.
• HPE (HPE) — $1.2B Vultr AI order and raised networking revenue outlook; a major validation of HPE's enterprise AI infrastructure strategy.
• Leslie's — Chapter 11 filing with plans to cut 90% of debt; a cautionary tale for over-leveraged discretionary retailers.
• Madison Square Garden Sports (MSGS) — Rangers/Knicks spinoff approved; a landmark sports franchise separation that could unlock significant value.
• Hormel Foods (HRL) — $1.055B Brakebush acquisition signals M&A appetite in packaged food despite a tough consumer backdrop.
• Peoples Bancorp (PEBO) — $728M Capital Bancorp deal continues the regional banking consolidation trend.
• Eli Lilly (LLY) — Three positive clinical readouts in a single day (cardiovascular, obesity, dermatitis) reinforces its position as the most prolific large-cap drug developer right now.
• AbbVie (ABBV) — Positive Phase 2 data for both zumilokibart and ABBV-295 on the same day; its post-Humira pipeline is building credibility.
• Bristol Myers Squibb (BMY) — FDA approval of CAMZYOS for pediatric obstructive cardiomyopathy expands a key franchise into a new patient population.
• Rocket Lab (RKLB) — 20-mission Synspective contract is one of its largest multi-launch commitments, anchoring near-term revenue visibility.
• Amentum (AMTM) — $2.78B UK nuclear contract win; nuclear services is an increasingly attractive defense-adjacent growth market.
• Mattel (MAT) — New Chairman/CEO Roger Lynch announced the same day the stock hit a 52-week low; turnaround mandate is clear.
• General Mills — Internal CEO succession (Dana McNabb) signals stability-first approach at a time of consumer staples margin pressure.
• CoreWeave (CRWV) — Launched Nvidia Vera Rubin NVL72 cloud service and announced NVIDIA Vera CPU addition; rapidly expanding its AI compute portfolio.
• Warner Bros. Discovery (WBD) — Hit a 52-week high as Paramount/WBD merger leadership (Ynon Kreiz as Co-CEO) takes shape.
• ADP Jobs Data — U.S. private sector added only 90,000 jobs in September, a notably soft reading that could influence Fed rate expectations.
• Palo Alto Networks (PANW) — All-time high at $399.03; cybersecurity remains one of the most resilient growth sectors in the current environment.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

👉 This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/